Analysis of the subunit stoichiometries in viral entry

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Magnus, Carsten ^a,b   Regoes, Roland R ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; ENVELOPE PROTEIN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41;

ARTICLE; BINDING SITE; CALCULATION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; MATHEMATICAL MODEL; MUTATION; NONHUMAN; PREDICTION; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR BINDING; STOICHIOMETRY; VIRION; VIRUS ENTRY; ALGORITHM; BIOLOGICAL MODEL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

ALGORITHMS; ANTIGENS, CD4; HIV; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTORS, CCR5; RECEPTORS, CXCR4; VIRUS INTERNALIZATION;

EID: 84859123277     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033441     Document Type: Article

References (38)

1. Earp L, Delos S, Park H, White J, (2004) The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol 285: 25-66.
2. Robey W, Safai B, Oroszlan S, Arthur L, Gonda M, et al. (1985) Characterization of envelope and core structural gene-products of HTLV-III with sera from AIDS patients. Science 228: 593-595.
3. Veronese F, Devico A, Copeland T, Oroszlan S, Gallo R, et al. (1985) Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229: 1402-1405.
4. Wyatt R, Sodroski J, (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280: 1884-1888.
5. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, et al. (1984) Tlymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312: 767-768.
6. Sattentau Q, Moore J, (1991) Conformational-changes induced in the humanimmunodeficiency-virus envelope glycoprotein by soluble cd4 binding. Journal of experimental medicine 174: 407-415.
7. Liu J, Bartesaghi A, Borgnia MJ, Sapiro G, Subramaniam S, (2008) Molecular architecture of native HIV-1 gp120 trimers. Nature 455: 109-U76.
8. Zhu P, Winkler H, Chertova E, Taylor KA, Roux KH, (2008) Cryoelectron tomography of hiv-1 envelope spikes: Further evidence for tripod-like legs. PLoS Pathog 4: e1000203.
9. Carlson LA, de Marco A, Oberwinkler H, Habermann A, Briggs JAG, et al. (2010) Cryo electron tomography of native HIV-1 budding sites. PLoS Pathog 6: 1-11.
10. Sougrat R, Bartesaghi A, Lifson JD, Bennett AE, Bess JW, et al. (2007) Electron tomography of the contact between T Cells and SIV/HIV-1: Implications for viral entry. PLoS Pathogens 3: 1-11.
11. Zanetti G, Briggs JAG, Grünewald K, Sattentau QJ, Fuller SD, (2006) Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ. PLoS Pathogens 2 (8): 790-797.
12. Schonning K, Lund O, Lund OS, Hansen JES, (1999) Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1. Journal of Virology pp. 8364-8370.
13. Yang X, Kurteva S, Ren X, Lee S, Sodroski J, (2005) Stoichiometry of envelope glycoprotein trimers in the entry of Human Immunodeficiency Virus type 1. Journal of Virology 79: 12132-47.
14. Klasse PJ, (2007) Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. Virology 369: 245-262.
15. Magnus C, Rusert P, Bonhoeffer S, Trkola A, Regoes RR, (2009) Estimating the stoichiometry of human immunodeficiency virus entry. Journal of Virology 83: 1523-1531.
16. Yang X, Kurteva S, Lee S, Sodroski J, (2005) Stoichiometry of antibody neutralization of Human Immunodeficiency Virus type 1. Journal of Virology 79: 3500-8.
17. Magnus C, Regoes RR, (2010) Estimating the stoichiometry of HIV neutralization. PLoS Comput Biol 6: e1000713.
18. Magnus C, Regoes R, (2011) Restricted occupancy models for neutralization of hiv virions and populations. Journal of Theoretical Biology 283: 192-202.
19. Yang X, Kurteva S, Ren X, Lee S, Sodroski J, (2006) Subunit stoichiometry of human immunodeficiency virus type 1 envelope glycoprotein trimers during virus entry into host cells. Journal of Virology 80: 4388-95.
20. Salzwedel K, Berger E, (2000) Cooperative subunit interactions within the oligomeric envelope glycoprotein of hiv-1: Functional complementation of specific defects in gp120 and gp41. Proceedings of the National Academy of Science USA 97: 12794-12799.
21. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, et al. (1996) Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. Journal of Virology 70: 1100-1108.
22. Doms R, Moore J, (2000) HIV-1 membrane fusion: Targets of opportunity. J Cell Biol 151: F9-F13.
23. Salzwedel K, Berger EA, (2009) Complementation of diverse HIV-1 Env defects through cooperative subunit interactions: a general property of the functional trimer. Retrovirology 6: 75.
24. Liu L, Cimbro R, Lusso P, Berger EA, (2011) Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer. Proceedings Of The National Academy Of Sciences Of The United States Of America 108: 20148-20153.
25. Doms RW, Earl PL, Chakrabarti S, Moss B, (1990) Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain. Journal of Virology 64: 3537-3540.
26. Zhu P, Liu J, Bess J Jr, Chertova E, Lifson JD, et al. (2006) Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441: 847-52.
27. Rusert P, Krarup A, Magnus C, Brandenberg OF, Weber J, et al. (2011) Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies. J Exp Med 208: 1419-1433.
28. Doms R, (2000) Beyond receptor expression: The inuence of receptor conformation, density, and affinity in HIV-1 infection. Virology 276: 229-237.
29. Lapham C, Ouyang J, Chandrasekhar B, Nguyen N, Dimitrov D, et al. (1996) Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274: 602-605.
30. Wu L, Gerard N, Wyatt R, Choe H, Parolin C, et al. (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384: 179-183.
31. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, et al. (1995) Structure of inuenza-virus hemagglutinin complexed with a neutralizing antibody. Nature 376: 92-94.
32. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, et al. (2006) Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. Journal of Virology 80: 5308-5320.
33. OpDeBeeck A, Voisset C, Bartosch B, Ciczora Y, Cocquerel L, et al. (2004) Characterization of functional hepatitis c virus envelope glycoproteins. Journal of Virology 78: 2994-3002.
34. Louder MKK, Sambor A, Chertova E, Hunte T, Barrett S, et al. (2005) HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity. Virology 339: 226-238.
35. Liu R, Paxton W, Choe S, Ceradini D, Martin S, et al. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377.
36. Lassen KG, Lobritz MA, Bailey JR, Johnston S, Nguyen S, et al. (2009) Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. PLoS Pathog 5: e1000377.
37. Mulampaka SN, Dixit NM, (2011) Estimating the threshold surface density of gp120-CCR5 complexes necessary for HIV-1 envelope-mediated cell-cell fusion. PLoS ONE 6: e19941.
38. Platt E, Wehrly K, Kuhmann S, Chesebro B, Kabat D, (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72: 2855-2864.